SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 248.28 |
| Enterprise Value ($M) | 265.94 |
| Book Value ($M) | -11.62 |
| Book Value / Share | -0.43 |
| Price / Book | -21.36 |
| NCAV ($M) | -13.64 |
| NCAV / Share | -0.50 |
| Price / NCAV | -18.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.83 |
| Return on Assets (ROA) | -0.74 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.00 |
| Current Ratio | 3.29 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 24.84 |
| Assets | 26.86 |
| Liabilities | 38.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 21.25 |
| Operating Income | -12.77 |
| Net Income | -16.05 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -17.14 |
| Cash from Investing | 0.00 |
| Cash from Financing | 6.64 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Solas Capital Management, LLC | 5.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 21,084 | 147,944 | 14.25 | |
| 35,225 | 107,185 | 32.86 | |
| 31,247 | 171,921 | 18.18 | |
| 43,128 | 53,408 | 80.75 | |
| 20,520 | 37,495 | 54.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EYEN – Eyenovia, Inc. | FBIO – Fortress Biotech, Inc. |
| FBRX – Forte Biosciences, Inc. | FLGC – Flora Growth Corp. |
| FTLF – FitLife Brands, Inc. |
Financial data and stock pages provided by
Fintel.io